BA
BHVN

Bridgewater Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bridgewater Associates’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,232
Closed -$640K – 953
2022
Q3 		$640K Sell
4,232
-2,076
-33% -$314K ﹤0.01% 753
2022
Q2 		$919K Buy
6,308
+408
+7% +$59.4K ﹤0.01% 799
2022
Q1 		$700K Buy
5,900
+1,782
+43% +$211K ﹤0.01% 846
2021
Q4 		$568K Buy
+4,118
New +$568K ﹤0.01% 635